JFL Life Sciences Limited
Fixed Price Issue IPO · NSE
- Price band
- ₹61 - ₹61
- Lot size
- 2,000 shares
- Issue amount
- ₹18.17 cr
- Total subscription
- 8.93×
- Opens
- 25 Aug 2022
- Closes
- 30 Aug 2022
- Allotment
- 6 Sept 2022
- Listing
- 8 Sept 2022
Offer at a glance
Issue overview
- Issue size
- 29,78,000 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹1,22,000
- Fresh issue
- ₹18.17 cr
- Offer for sale
- ₹0 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,22,000
- Issue type
- Fixed Price Issue IPO
- Shares before issue
- 80,20,441
- Shares after issue
- 1,09,98,441
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 2,000 | ₹1,22,000 |
| HNI | 2 | 4,000 | ₹2,44,000 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
JFL Life Sciences Limited, established in 2010, is a pharmaceutical company specializing in the manufacturing of a variety of medicines. Its product range includes dry powder injections (B-Lactam), tablets, capsules (B-Lactam and general), and oral rehydration solutions (ORS). The company follows a bulk sales strategy, supplying its products to pharmaceutical marketers and traders who then distribute them to customers. JFL has a strong presence across India and exports to 10 countries worldwide. Internationally, JFL supplies products to African, Middle Eastern, and CIS countries through merchant exporters. The company is also registered with the Ministries of Health (MOH) in Kenya, Nigeria, Yemen, Cambodia, and Myanmar for specific products, with additional registrations in Ukraine, Uzbekistan, and Kazakhstan. JFL operates two leased manufacturing units in Gujarat to produce its pharmaceutical products.
Strengths
- Product Registration: Approved by health authorities in multiple countries, ensuring global market access.
- Experienced Leadership & Skilled Team: Led by industry experts with a dedicated workforce committed to excellence.
- Quality Assurance: Strict quality control measures to maintain high standards in manufacturing.
- Strong Brand & Reliability: Well-known for delivering trusted and effective pharmaceutical products.
Promoters
Smiral Ashwinkumar Patel
ejal Smiral Patel
Registrar & documents
Lead manager
GYR Capital Advisors Private Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
309, Satyam Mall, Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir Settelite, Ahmedabad 380015
937729 5575
[email protected]Company website ↗Understanding JFLLIFE IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.